G. Mestre

A prospective trial of structured treatment interruptions in human immunodeficiency virus infection.

A. Telenti, T. Perneger, H. Günthard, 2003, Archives of internal medicine.

Metabolic and Immunological Effects of Antiretroviral Agents in Healthy Individuals Receiving Post-Exposure Prophylaxis

Felipe García, G. Mestre, M. Plana, 2001, Antiviral therapy.

Long-Term CD4+ T-Cell Response to Highly Active Antiretroviral Therapy According to Baseline CD4+ T-Cell Count

Felipe García, G. Mestre, M. Plana, 2004, Journal of acquired immune deficiency syndromes.

Genotypic and Phenotypic Resistance Patterns in Early-Stage HIV-1-Infected Patients Failing Initial Therapy with Stavudine, Didanosine and Nevirapine

Felipe García, G. Mestre, M. Plana, 2001, Antiviral therapy.

Predictors of Tonsillar Tissue HIV-1 Viral Burden at Baseline and after 1 Year of Antiretroviral Therapy

Felipe García, G. Mestre, M. Plana, 2002, Antiviral therapy.

Short Communication: Natural killer cells and expression of KIR receptors in chronic HIV type 1-infected patients after different strategies of structured therapy interruption.

Felipe García, G. Mestre, M. Plana, 2008, AIDS research and human retroviruses.

Relevance of HIV-1-Specific CD4+ Helper T-Cell Responses During Structured Treatment Interruptions in Patients With CD4+ T-Cell Nadir Above 400/mm3

G. M. Ortiz, D. Nixon, C. Fagard, 2004, Journal of acquired immune deficiency syndromes.